Directive 1998/44 - Legal protection of biotechnological inventions - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
Contents
official title
Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions| Legal instrument | Directive |
|---|---|
| Number legal act | Directive 1998/44 |
| Original proposal | COM(1995)661  |
| CELEX number i | 31998L0044 |
| Document | 06-07-1998 |
|---|---|
| Publication in Official Journal | 30-07-1998; Special edition in Romanian: Chapter 13 Volume 023,Special edition in Hungarian: Chapter 13 Volume 020,Special edition in Czech: Chapter 13 Volume 020,Special edition in Maltese: Chapter 13 Volume 020,Special edition in Slovak: Chapter 13 Volume 020,Special edition in Croatian: Chapter 13 Volume 062,Special edition in Slovenian: Chapter 13 Volume 020,Special edition in Latvian: Chapter 13 Volume 020,Special edition in Polish: Chapter 13 Volume 020,OJ L 213, 30.7.1998,Special edition in Bulgarian: Chapter 13 Volume 023,Special edition in Estonian: Chapter 13 Volume 020,Special edition in Lithuanian: Chapter 13 Volume 020 |
| Effect | 30-07-1998; Entry into force Date pub. See Art 17 |
| Deadline | 30-07-2000; See Art 16 |
| End of validity | 31-12-9999 |
| Transposition | 30-07-2000; At the latest See Art 15 |
30.7.1998 |
EN |
Official Journal of the European Communities |
L 213/13 |
DIRECTIVE 98/44/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
of 6 July 1998
on the legal protection of biotechnological inventions
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty establishing the European Community, and in particular Article 100a thereof,
Having regard to the proposal from the Commission (1),
Having regard to the opinion of the Economic and Social Committee (2),
Acting in accordance with the procedure laid down in Article 189b of the Treaty (3),
(1) |
Whereas biotechnology and genetic engineering are playing an increasingly important role in a broad range of industries and the protection of biotechnological inventions will certainly be of fundamental importance for the Community's industrial development; |
(2) |
Whereas, in particular in the field of genetic engineering, research and development require a considerable amount of high-risk investment and therefore only adequate legal protection can make them profitable; |
(3) |
Whereas effective and harmonised protection throughout the Member States is essential in order to maintain and encourage investment in the field of biotechnology; |
(4) |
Whereas following the European Parliament's rejection of the joint text, approved by the Conciliation Committee, for a European Parliament and Council Directive on the legal protection of biotechnological inventions (4), the European Parliament and the Council have determined that the legal protection of biotechnological inventions requires clarification; |
(5) |
Whereas differences exist in the legal protection of biotechnological inventions offered by the laws and practices of the different Member States; whereas such differences could create barriers to trade and hence impede the proper functioning of the internal market; |
(6) |
Whereas such differences could well become greater as Member States adopt new and different legislation and administrative practices, or whereas national case-law interpreting such legislation develops differently; |
(7) |
Whereas uncoordinated development of national laws on the legal protection of biotechnological inventions in the Community could lead to further disincentives to trade, to the detriment of the industrial development of such inventions and of the smooth operation of the internal market; |
(8) |
Whereas legal protection of biotechnological inventions does not necessitate the creation of a separate body of law in place of the rules of national patent law; whereas the rules of national patent law remain the essential basis for the legal protection of biotechnological inventions given that they must be adapted or added to in certain specific respects in order to take adequate account of technological developments involving biological material which also fulfil the requirements for patentability; |
(9) |
Whereas in certain cases, such as the exclusion from patentability of plant and animal varieties and of essentially biological processes for the production of plants and animals, certain concepts in national laws based upon international patent and plant variety conventions have created uncertainty regarding the protection of biotechnological and certain microbiological inventions; whereas harmonisation is necessary to clarify the said uncertainty; |
(10) |
Whereas regard should be had to the potential of the development of biotechnology for the environment and in particular the utility of this technology for the development of methods of cultivation which are less polluting and more economical in their use of ground; whereas the patent system should be used to encourage research into, and the application of, such... |
More
This text has been adopted from EUR-Lex.
This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.
This page is also available in a full version containing the summary of legislation, the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and finally the related cases of the European Court of Justice.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.